Get started
Work

Data Supplement from Discordant In Vitro and In Vivo Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts

Year: 2023
Type: other
Abstract: Supplementary Figure S5. Effects of Veliparib on TMZ induced DNA damage signaling in undifferentiated or differentiated GBM12 cells
DOI: 10.1158/1078-0432.22455251.v1
Authors: Shiv K. Gupta, Ann C. Mladek, Brett L. Carlson, Felix Boakye-Agyeman, Katrina K. Bakken, Sani H. Kizilbash, Mark A. Schroeder, Joel Reid, Jann N. Sarkaria
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361910151
Cites:
Cited by:
Related to: 10